Kukje Pharma Co Ltd (002720) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Kukje Pharma Co Ltd (002720) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.99 Billion ≈ $3.38 Million USD) by net assets (₩95.32 Billion ≈ $64.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Kukje Pharma Co Ltd for the company's overall valuation and market capitalisation.

Kukje Pharma Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Kukje Pharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kukje Pharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kukje Pharma Co Ltd ranked by their cash flow conversion efficiency. Explore 002720 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Vishnu Prakash R Punglia Limited NSE:VPRPL	0.089x
Gielda Praw Majatkowych Vindexus S.A. WAR:VIN	0.056x
Kandi Technologies Group Inc NASDAQ:KNDI	-0.359x
Matang Bhd KLSE:0189	0.010x
Marathon Bancorp, Inc. Common Stock NASDAQ:MBBC	0.003x
Arianne Phosphate Inc V:DAN	-0.019x
Asian Pac Holdings Bhd KLSE:4057	-0.011x
Korea Steel Co Ltd KO:007280	0.038x

Annual Cash Flow Conversion Efficiency for Kukje Pharma Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Kukje Pharma Co Ltd from 2011 to 2024. View Kukje Pharma Co Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩89.55 Billion ≈ $60.69 Million	₩3.94 Billion ≈ $2.67 Million	0.044x	+4.54%
2023-12-31	₩84.95 Billion ≈ $57.57 Million	₩3.58 Billion ≈ $2.42 Million	0.042x	-52.06%
2022-12-31	₩74.08 Billion ≈ $50.20 Million	₩6.50 Billion ≈ $4.41 Million	0.088x	-37.26%
2021-12-31	₩68.59 Billion ≈ $46.48 Million	₩9.60 Billion ≈ $6.50 Million	0.140x	+93.42%
2020-12-31	₩70.50 Billion ≈ $47.78 Million	₩5.10 Billion ≈ $3.46 Million	0.072x	+22.36%
2019-12-31	₩60.95 Billion ≈ $41.31 Million	₩3.60 Billion ≈ $2.44 Million	0.059x	-69.34%
2018-12-31	₩68.70 Billion ≈ $46.56 Million	₩13.25 Billion ≈ $8.98 Million	0.193x	+1562.80%
2017-12-31	₩67.78 Billion ≈ $45.93 Million	₩786.10 Million ≈ $532.73K	0.012x	-95.14%
2016-12-31	₩67.52 Billion ≈ $45.76 Million	₩16.10 Billion ≈ $10.91 Million	0.238x	+421.30%
2015-12-31	₩68.46 Billion ≈ $46.39 Million	₩-5.08 Billion ≈ $-3.44 Million	-0.074x	-6075.28%
2014-12-31	₩50.85 Billion ≈ $34.46 Million	₩-61.11 Million ≈ $-41.41K	-0.001x	+98.47%
2013-12-31	₩58.33 Billion ≈ $39.53 Million	₩-4.60 Billion ≈ $-3.11 Million	-0.079x	-376.04%
2012-12-31	₩55.35 Billion ≈ $37.51 Million	₩1.58 Billion ≈ $1.07 Million	0.029x	-87.72%
2011-12-31	₩74.79 Billion ≈ $50.69 Million	₩17.39 Billion ≈ $11.78 Million	0.232x	--

About Kukje Pharma Co Ltd

KO:002720 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$44.92 Million

₩66.28 Billion KRW

Market Cap Rank

#22387 Global

#1427 in Korea

Share Price

₩3255.00

Change (1 day)

+0.15%

52-Week Range

₩3045.00 - ₩5230.00

All Time High

₩12612.03